SC
Saras Capital
Activity from announced rounds
Activity in this selectionSeries B
Saras Capital is the investor linked by Biographica, Converge and Shennon sources to Nadav Rosenberg.
Recorded funding activity
Biographica develops crop traits using AI discovery. Converge supplies drug-discovery models, while Shennon develops cancer therapies. These company records preserve separate biological applications and financing events.
- Rounds participated in
- 0
- Confirmed lead rounds
- — All roles disclosed
- New companies
- 0 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share
By stage
No activity in this selection.
By primary sector
No activity in this selection.
By country
No activity in this selection.
Rounds
0 in this selectionNo rounds match this selection.